Suchergebnisse - "Xiao, Jun"

PubPharm (115)

1

Chitosan inhibits vascular intimal hyperplasia via LINC01615/MIR-185-5p/PIK3R2 signaling pathway

enthalten in: Gene | 2024

von Yan, Y. | Wu, Q. | Li, J. | +11

2

Identification and characterization of differentially expressed genes in cervical cancer : insights from transcriptomic analysis

enthalten in: Cellular and molecular biology (Noisy-le-Grand, France) | 2023

von Haojue Wang | Xianyi Lu | Ling Fang | +2

3

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis

enthalten in: Cell death & disease | 2023

von Guo, X. | Huang, X. | Yang, X. | +15

4

A novel gut-restricted RIPK1 inhibitor, SZ-15, ameliorates DSS-induced ulcerative colitis

enthalten in: European journal of pharmacology | 2022

von Zeng, Y. | Peng, J. | Gao, X. | +12

5

LncRNA THOR promotes endometrial cancer progression through the AKT and ERK signaling pathways

enthalten in: Medical oncology (Northwood, London, England) | 2022

von Zhang, H. | Li, T. | Li, C. | +6

6

hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype

enthalten in: Journal of hematology & oncology | 2022

von Su, Y. | Sun, X. | Liu, X. | +9

ErratumIn: J Hematol Oncol. 2022 Jul 31;15(1):102. - PMID 35909099

7

Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming

enthalten in: Acta pharmacologica Sinica | 2022

von Wang, P. | Jin, J. | Liang, X. | +10

8

AKT2 reduces IFNβ1 production to modulate antiviral responses and systemic lupus erythematosus

enthalten in: The EMBO journal | 2022

von Zheng, X. | Xiao, J. | Jiang, Q. | +16

9

Pyronaridine induces apoptosis in non-small cell lung cancer cells by upregulating death receptor 5 expression and inhibiting epidermal growth factor receptor

enthalten in: Chemical biology & drug design | 2022

von Zhong, Z. | Yi, Z. | Zhao, Y. | +11

10

LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis

enthalten in: Oxidative medicine and cellular longevity | 2022

von Mu, X. | Shen, Z. | Lin, Y. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]